Increasing circulating exosomes‐carrying TRPC5 predicts chemoresistance in metastatic breast cancer patients

por Wang, Teng, Ning, Kuan, Lu, Ting‐xun, Sun, Xu, Jin, Linfang, Qi, Xiaowei, Jin, Jian, Hua, Dong
Publicado 2017

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma

por Lu, Ting-Xun, Wu, Shuang, Cai, Dong-Yan, Hong, Ting-Ting, Zhang, Ying, Gao, Hua-Qiang, Hua, Hai-Ying, Wu, Xiao-Hong
Publicado 2019

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma

por Wu, Shuang, Zhou, Ye, Hua, Hai-Ying, Zhang, Yan, Zhu, Wen-Yan, Wang, Zhi-Qing, Li, Jin, Gao, Hua-Qiang, Wu, Xiao-Hong, Lu, Ting-Xun, Hua, Dong
Publicado 2018

Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age

por Lu, Ting-Xun, Liang, Jin-Hua, Miao, Yi, Fan, Lei, Wang, Li, Qu, Xiao-Yan, Cao, Lei, Gong, Qi-Xing, Wang, Zhen, Zhang, Zhi-Hong, Xu, Wei, Li, Jian-Yong
Publicado 2015

MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma

por Lu, Ting-Xun, Fan, Lei, Wang, Li, Wu, Jia-Zhu, Miao, Kou-Rong, Liang, Jin-Hua, Gong, Qi-Xing, Wang, Zhen, Young, Ken H., Xu, Wei, Zhang, Zhi-Hong, Li, Jian-Yong
Publicado 2015

The distinct clinical features and prognosis of the CD10(+)MUM1(+) and CD10(−)Bcl6(−)MUM1(−) diffuse large B-cell lymphoma

por Lu, Ting-Xun, Miao, Yi, Wu, Jia-Zhu, Gong, Qi-Xing, Liang, Jin-Hua, Wang, Zhen, Wang, Li, Fan, Lei, Hua, Dong, Chen, Yao-Yu, Xu, Wei, Zhang, Zhi-Hong, Li, Jian-Yong
Publicado 2016